Theradiag SA
Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize imag… Read more
Theradiag SA (ALTHE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 1.404x
Based on the latest financial reports, Theradiag SA (ALTHE) has a cash flow conversion efficiency ratio of 1.404x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.56 Million) by net assets (€-2.54 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Theradiag SA - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Theradiag SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Theradiag SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Theradiag SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Elco Ltd
TA:ELCO
|
0.043x |
|
Kingswood Holdings Limited
PINK:KWGHF
|
0.051x |
|
Global AI Inc
OTCQB:GLAI
|
0.889x |
|
Auctus Alternative Investments Ltd
AU:AVC
|
0.026x |
|
Austral Resources Australia Ltd
AU:AR1
|
-0.065x |
|
Sing Tao News Corporation Limited
PINK:STAOF
|
0.001x |
|
Harn Len Corporation Bhd
KLSE:7501
|
0.080x |
|
Rail Vision Ltd. Ordinary Share
NASDAQ:RVSN
|
-0.103x |
Annual Cash Flow Conversion Efficiency for Theradiag SA (2011–2024)
The table below shows the annual cash flow conversion efficiency of Theradiag SA from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €-114.00 | €-2.91 Million | 25535.088x | +5810417.91% |
| 2023-12-31 | €5.65 Million | €-2.48 Million | -0.439x | +95.45% |
| 2022-12-31 | €544.87K | €-5.27 Million | -9.665x | -416.71% |
| 2021-12-31 | €-1.27 Million | €-3.88 Million | 3.052x | +197.46% |
| 2020-12-31 | €-3.24 Million | €-3.32 Million | 1.026x | -97.79% |
| 2019-12-31 | €-79.73K | €-3.69 Million | 46.321x | +420.83% |
| 2018-12-31 | €-531.93K | €-4.73 Million | 8.894x | +554.82% |
| 2017-12-31 | €3.47 Million | €-6.79 Million | -1.955x | -37.04% |
| 2016-12-31 | €5.58 Million | €-7.97 Million | -1.427x | +78.31% |
| 2015-12-31 | €756.80K | €-4.98 Million | -6.579x | -252.44% |
| 2014-12-31 | €2.77 Million | €-5.18 Million | -1.867x | -275.77% |
| 2013-12-31 | €-3.80 Million | €-4.04 Million | 1.062x | +111.88% |
| 2012-12-31 | €297.60K | €-2.66 Million | -8.938x | -13.01% |
| 2011-12-31 | €120.37K | €-952.02K | -7.909x | -- |